ORTHO-NOVUM 1/35-28
LOE ApproachingNDAORAL-28TABLET
Approved
Jun 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ORTHO-NOVUM 1/35-28 is an oral contraceptive tablet containing norethindrone and ethinyl estradiol in a 28-day cycle formulation. It prevents pregnancy through hormonal suppression of ovulation and is among the longest-established combination oral contraceptives in the U.S. market. This small-molecule product represents a foundational therapy in women's reproductive health.
LOE Approaching
Product is in late lifecycle stage with moderate competitive pressure (30); limited job creation expected as brand transitions toward genericization and market consolidation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ORTHO-NOVUM 1/35-28 offers experience in mature product stewardship, generic transition strategy, and formulary management in women's health—valuable expertise for portfolio optimization and LOE planning. However, limited commercial expansion and zero linked job openings indicate this is a defensive maintenance role rather than a growth opportunity.
Brand Manager
Worked on ORTHO-NOVUM 1/35-28 at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.